{"denomUnitsSelected":"Participants","description":"Bone marrow minimal residual disease (MRD) negativity will be defined as the ratio of subjects who achieved MRD to all subjects. MRD negativity will be assessed by next-generation sequencing with a minimum sensitivity of 1x10-5.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 12 weeks","title":"Bone Marrow Minimal Residual Disease (MRD) Negativity","type":"SECONDARY"}